文 晏国文 卢志坤 最近，湖北血液透析患者陶勇（化名）注意到，他定期进行血液透析的医院淘汰了一批用了接近20年的 进口与合资的血液透析机。 现在，他所在的透析室进口、合资、国产的透析机都有。目前他主要使用的是某合资品牌透析机。同 时，对新来的国产血透设备，他有些好奇，也有些期待。 "我听医生讲，国产设备跟旧的进口或合资的机器相差不大，功能基本相同，不过具体表现怎样还有待 观察。总体来说，需要看长期效果。"2025年12月29日，陶勇对《中国经营报》记者说，血透患者最主 要的期望就是提高透析质量，降低个人费用。国产创新医疗设备崛起，这肯定是行业发展大趋势。 "在过去及现在很长一段时间内，国外血透厂商长期垄断着高精度传感器、在线监测算法等核心技术， 国外厂商专利布局密集。国产企业起步晚，研发周期长、投入大，中试到量产的工艺要求多、难度大。 在此情况下，血透市场长期被外资品牌占据，临床医生对设备的操作习惯、治疗模式已形成一定的品牌 壁垒，对国产设备运行稳定性、并发症控制等方面存在顾虑。"针对血液透析设备行业发展情况，2025 年12月26日，三鑫医疗（300453.SZ）方面对记者表示。 三鑫医疗方面对记者介绍，中 ...

Core Insights - The article highlights the transformation and innovation within Jiangxi's industries, showcasing local companies that are revitalizing traditional sectors while embracing new technologies and business models [1][2][3] Group 1: Industry Transformation - Jiangxi's traditional industries, which account for nearly 70% of its industrial output, are being revitalized through initiatives that focus on technological upgrades and collaborative improvements within the supply chain [1] - The provincial government emphasizes the importance of nurturing new productive forces while not dismissing traditional industries as low-end, aiming for a balanced approach to economic development [1] Group 2: Company Innovations - Fushite is transitioning from a traditional manufacturing model to a service-oriented approach, expanding its offerings from hydraulic pipes to comprehensive equipment health management, thus identifying new growth areas [2] - Jiangxi's manufacturing sector has seen significant digital transformation, with over 12,000 companies undergoing upgrades, leading to a structural change in digital capabilities and over 2,500 firms advancing from digital to intelligent operations [2] - Nairui Mining Machinery has evolved from selling parts to becoming a comprehensive service provider in the mining sector, illustrating a shift towards higher value in the industry [3] - Sanxin Medical has successfully developed a domestic blood dialysis membrane, overcoming previous industry challenges and achieving a fourfold revenue increase over ten years, marking a significant advancement in Jiangxi's medical device sector [3]